Home > News > Disease diagnosis, drug development focus of UH prof's biochip research
September 1st, 2004
Disease diagnosis, drug development focus of UH prof's biochip research
Abstract:
Leading the way to disease diagnosis and drug development, biochip research at the University of Houston will be presented to an international audience of top nanoscientists next week. B. Montgomery Pettitt, the Hugh Roy and Lillie Cranz Cullen Distinguished Professor of Chemistry at the University of Houston, has been selected as one of the plenary speakers at the Pacific Rim Nanoscience Conference Sept. 7-11 in Broome, Western Australia. Pettitt is one of only three American scientists among the 21 invited speakers.
Source:
medicalnewstoday
Bookmark:
| Related News Press |
Nanomedicine
Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Self-propelled protein-based nanomotors for enhanced cancer therapy by inducing ferroptosis June 6th, 2025
Announcements
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||